Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Productie van analytische laboratoriuminstrumenten”
Aandelen in “Productie van analytische laboratoriuminstrumenten”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Productie van analytische laboratoriuminstrumenten”
Toon enkel gratis nieuws
11/09 ·
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
· Persbericht
11/09 ·
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
· Persbericht
6/09 ·
AI-favoriet Bloom Energy en genomicapionier Illumina komen in S&P500
· Tijd.be (€)
De nieuwe, toekomstige leden van de S&P500 gaan een sterke beurssessie tegemoet. Zo'n 20.000 miljard dollar is op de of andere manier gekoppeld aan de beursbarometer.
26/08 ·
EyePoint Pharmaceuticals (EYPT) Securities Investigation Notice - Levi & Korsinsky
· Persbericht
26/08 ·
Waters Corporation to Present at the Wells Fargo Healthcare Conference
· Persbericht
20/08 ·
EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals
· Persbericht
13/08 ·
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
· Persbericht
5/08 ·
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
· Persbericht
4/08 ·
Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
· Persbericht
30/07 ·
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
· Persbericht
29/07 ·
Avantor® Reports Second Quarter 2026 Results
· Persbericht
27/07 ·
Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
· Persbericht
16/07 ·
Illumina expands Billion Cell Atlas program with new AI drug developers
· Persbericht
14/07 ·
Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product
· Persbericht
13/07 ·
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
· Persbericht
9/07 ·
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
· Persbericht
9/07 ·
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
· Persbericht
6/07 ·
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
· Persbericht
2/07 ·
Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
· Persbericht
1/07 ·
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026
· Persbericht
26/06 ·
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe